Quick verdict
LifeMD is the better pick for most patients on overall scoring. Mature publicly-traded telehealth with rare direct-supply deals from both Novo Nordisk and Eli Lilly. Reasonable $79/mo membership floor, intro Wegovy/Ozempic at $199 for first two fills, and Zepbound vials from $349. Insurance navigation included. Money-back guarantee if member doesn't lose 10%+ in a year.
That said, Embla wins on specific dimensions. Embla is the closest thing the US market has to a Noom-meets-Calibrate hybrid that actually leans into the medication. Heavy behavioral coaching, branded-first prescribing, structured 12-month curriculum. Best for buyers who want the program to do half the work.
Side-by-side
| Embla | LifeMD | |
|---|---|---|
| Starts from | $249/mo (+ med separate) | $79/mo (+ med separate) |
| Lock-in | 12-month commitment | Month-to-month |
| Time to prescription | 7 days | 2 days |
| Consultation type | Synchronous | Async |
| Affiliate network | Impact | Impact |
Score by dimension
Five dimensions, ten points each. The winner of each dimension is highlighted.
| Embla | LifeMD | |
|---|---|---|
| Pricing transparency | 6/10 | 8/10 |
| Cancellation terms | 7/10 | 7/10 |
| Onboarding experience | 6/10 | 9/10 |
| Medication options | 7/10 | 9/10 |
| Member outcomes | 8/10 | 7/10 |
When to choose Embla
Patients who tried meds-only and bounced, and want a structured behavior program alongside GLP-1.
When to choose LifeMD
Mainstream patients who want insurance navigation plus the option to cash-pay for branded GLP-1 at near-NovoCare/LillyDirect rates without leaving the platform.
FAQ
Is Embla cheaper than LifeMD?
Can I switch from Embla to LifeMD mid-treatment?
Which program has better member feedback?
Read the full reviews
All head-to-head comparisons → · Full chart →